| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 华挺 | 财通证券 | 医药生物 | 38.89% | 37.23% | 14.81% | -6.67% | 7 | -50.33% | 2025-08-08 |
| 2 | 周豫 | 太平洋 | 医药生物 | 38.87% | 45.17% | 32.31% | 20.00% | 23 | -55.62% | 2025-07-18 |
| 3 | 王斌 | 首创证券 | 医药生物 | 38.86% | 38.06% | 24.98% | -3.03% | 19 | -54.62% | 2025-08-14 |
| 4 | 仰佳佳 | 申万宏源 | 医药生物 | 38.85% | 43.88% | 8.97% | 16.67% | 1 | -37.64% | 2025-07-17 |
| 5 | 王班 | 民生证券 | 医药生物 | 38.83% | 42.16% | 29.66% | -21.43% | 15 | -61.25% | 2025-08-01 |
| 6 | 王班 | 民生证券 | 医药生物 | 38.82% | 33.31% | 27.56% | -21.43% | 15 | -61.25% | 2025-08-14 |
| 7 | 马云涛 | 国元证券 | 医药生物 | 38.79% | 39.43% | 18.64% | -12.00% | 1 | -47.07% | 2025-08-14 |
| 8 | 叶思奥 | 光大证券 | 医药生物 | 38.74% | 41.58% | 46.92% | -60.00% | 3 | -47.18% | 2025-08-01 |
| 9 | 万鹏辉 | 国海证券 | 医药生物 | 38.72% | 45.16% | 20.78% | 100.00% | 5 | 0.00% | 2025-08-04 |
| 10 | 万鹏辉 | 国海证券 | 医药生物 | 38.62% | 32.37% | 20.31% | 100.00% | 5 | 0.00% | 2025-08-11 |
| 11 | 王班 | 民生证券 | 医药生物 | 38.61% | 45.26% | 29.45% | -21.43% | 15 | -61.25% | 2025-08-04 |
| 12 | 仰佳佳 | 申万宏源 | 医药生物 | 38.60% | 42.03% | 29.51% | 16.67% | 1 | -37.64% | 2025-06-23 |
| 13 | 唐寅灏 | 中信证券 | 医药生物 | 38.58% | 24.95% | 28.41% | 60.00% | 12 | -8.47% | 2025-05-29 |
| 14 | 李安飞 | 广发证券 | 医药生物 | 38.54% | 29.77% | 35.13% | 2.86% | 1 | -56.96% | 2025-05-07 |
| 15 | 杨松 | 天风证券 | 医药生物 | 38.53% | 38.75% | 28.88% | -45.36% | 19 | -72.65% | 2025-08-12 |
| 16 | 万鹏辉 | 国海证券 | 医药生物 | 38.51% | 38.19% | 20.59% | 100.00% | 5 | 0.00% | 2025-08-05 |
| 17 | 袁聪敏 | 中信证券 | 医药生物 | 38.48% | 35.07% | 29.83% | 33.33% | 1 | -2.06% | 2025-04-30 |
| 18 | 王道 | 申万宏源 | 医药生物 | 38.45% | 38.55% | 40.35% | -11.11% | 4 | -42.73% | 2025-08-11 |
| 19 | 仰佳佳 | 申万宏源 | 医药生物 | 38.43% | 41.07% | 31.62% | 16.67% | 1 | -37.64% | 2025-06-10 |
| 20 | 张林晚 | 上海证券 | 医药生物 | 38.42% | 43.65% | 33.68% | -100.00% | 1 | -18.93% | 2025-07-15 |